These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations. Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I. Int J Antimicrob Agents; 2007 Mar 29; 29(3):322-5. PubMed ID: 17204403 [Abstract] [Full Text] [Related]
23. Antimicrobial-resistant enterococci in animals and meat: a human health hazard? Hammerum AM, Lester CH, Heuer OE. Foodborne Pathog Dis; 2010 Oct 29; 7(10):1137-46. PubMed ID: 20578915 [Abstract] [Full Text] [Related]
24. Vancomycin-resistant Enterococcus faecium osteomyelitis: successful treatment with quinupristin-dalfopristin. Summers M, Misenhimer GR, Antony SJ. South Med J; 2001 Mar 29; 94(3):353-5. PubMed ID: 11284529 [Abstract] [Full Text] [Related]
25. Quinupristin-dalfopristin and linezolid: evidence and opinion. Eliopoulos GM. Clin Infect Dis; 2003 Feb 15; 36(4):473-81. PubMed ID: 12567306 [Abstract] [Full Text] [Related]
26. Glycopeptide-resistant enterococci: deciphering virulence, resistance and epidemicity. Willems RJ, Bonten MJ. Curr Opin Infect Dis; 2007 Aug 15; 20(4):384-90. PubMed ID: 17609597 [Abstract] [Full Text] [Related]
36. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Jones RN, Fritsche TR, Sader HS, Ross JE. Diagn Microbiol Infect Dis; 2007 Nov 15; 59(3):309-17. PubMed ID: 17720350 [Abstract] [Full Text] [Related]